EQTEC Plc (AIM: EQT) shares shot up in Wednesday’s early deals after announcing an agreement to develop the Billingham waste-to-energy project in county Durham.
UK medicinal cannabis firm Sativa Investments PLC (NEX:SATI) has decided to allow an option over a farm in Wilshire to grow its own produce to lapse in July. The company also announced that it plans to change its name to Sativa Group alongside an amended strategy.
BigDish PLC (LON:DISH) is aiming to launch its restaurant booking platform in four more towns and cities by the end of May, having already gone live in Exeter and Basingstoke at the start of the month.
Argo Blockchain PLC (LON:ARB) shares surged on Wednesday after it forecast breakeven earnings (EBITDA) in the second half of the year and brought new units online to boost its cryptocurrency mining capacity.
AfriTin Mining Limited (LON:ATM) has signed a deal with Namibia Power over grid electricity for the pilot plant at the Uis tin mine.
Shield Therapeutics PLC (LON: STX) has appointed finnCap Ltd as its joint broker with immediate effect.
Sareum Holdings PLC’s (LON:SAR) licence partner Sierra Oncology is currently analysing preliminary data from two ongoing phase 1 and 2 clinical trials evaluating SRA737 monotherapy and SRA737+LDG combination therapy for the treatment of cancer. Sierra expects to report on these studies and potential next steps at the 2019 American Society of Clinical Oncology (ASCO) meeting on June 1.
Kibo Energy PLC (LON:KIBO) said its 65%-owned Benga power plant project is advancing well ahead of its development schedule. It has presented a definitive feasibility study on the project to Mozmabique’s ministry of energy and state-owned electric utility, Electricidade de Mocambique (EDM).
The company completed 1,687m of reverse circulation drilling in 17 holes at the project targeting multiple quartz vein orientations within the Dimocks Main Shale (DMS).
BB Healthcare Trust PLC (LON:BBH) said it is to issue £2.1mln worth of its ordinary shares. Some 1.5mln ordinary shares will be issued at a price of 136.2p each, a premium to the prevailing net asset value per share.